Simerska P[auth] - Search Results

Year	Number of Results
2003	1
2006	1
2007	2
2008	5
2009	6
2010	2
2011	2
2012	3
2013	2
2014	7
2015	3
2016	3
2017	2
2019	1
2024	0

1

Aljohani S, Hussein WM, Toth I, Simerska P. Aljohani S, et al. Among authors: simerska p. Curr Drug Deliv. 2019;16(7):609-617. doi: 10.2174/1567201816666190702153612. Curr Drug Deliv. 2019. PMID: 31267872 Review.

2

Peptides as therapeutics with enhanced bioactivity.

Goodwin D, Simerska P, Toth I. Goodwin D, et al. Among authors: simerska p. Curr Med Chem. 2012;19(26):4451-61. doi: 10.2174/092986712803251548. Curr Med Chem. 2012. PMID: 22830348 Review.

3

Chemical methods for peptide and protein production.

Chandrudu S, Simerska P, Toth I. Chandrudu S, et al. Among authors: simerska p. Molecules. 2013 Apr 12;18(4):4373-88. doi: 10.3390/molecules18044373. Molecules. 2013. PMID: 23584057 Free PMC article. Review.

4

Biophysical characterization of lectin-glycan interactions for therapeutics, vaccines and targeted drug-delivery.

Christie MP, Toth I, Simerská P. Christie MP, et al. Among authors: simerska p. Future Med Chem. 2014;6(18):2113-29. doi: 10.4155/fmc.14.130. Future Med Chem. 2014. PMID: 25531972 Review.

5

Modern lipid-, carbohydrate-, and peptide-based delivery systems for peptide, vaccine, and gene products.

Simerska P, Moyle PM, Toth I. Simerska P, et al. Med Res Rev. 2011 Jul;31(4):520-47. doi: 10.1002/med.20191. Epub 2009 Dec 21. Med Res Rev. 2011. PMID: 20027671 Review.

6

Oral vaccine delivery--new strategies and technologies.

Simerska P, Moyle PM, Olive C, Toth I. Simerska P, et al. Curr Drug Deliv. 2009 Aug;6(4):347-58. doi: 10.2174/156720109789000537. Epub 2009 Aug 1. Curr Drug Deliv. 2009. PMID: 19534712 Review.

7

Synthetic polyacrylate polymers as particulate intranasal vaccine delivery systems for the induction of mucosal immune response.

Zaman M, Simerska P, Toth I. Zaman M, et al. Among authors: simerska p. Curr Drug Deliv. 2010 Apr;7(2):118-24. doi: 10.2174/156720110791011846. Curr Drug Deliv. 2010. PMID: 20158484 Review.

8

Evaluation of Lipopeptides as Toll-like Receptor 2 Ligands.

Hussein WM, Choi PM, Zhang C, Su M, Sierecki E, Johnston W, Fagan V, Alexandrov K, Skwarczynski M, Gambin Y, Toth I, Simerska P. Hussein WM, et al. Among authors: simerska p. Curr Drug Deliv. 2017;14(7):935-943. doi: 10.2174/1567201813666160804114107. Curr Drug Deliv. 2017. PMID: 27494158

9

Stability, permeability and growth-inhibitory properties of gonadotropin-releasing hormone liposaccharides.

Goodwin D, Varamini P, Simerska P, Toth I. Goodwin D, et al. Among authors: simerska p. Pharm Res. 2015 May;32(5):1570-84. doi: 10.1007/s11095-014-1558-1. Epub 2014 Nov 19. Pharm Res. 2015. PMID: 25407542

10

Systematic evaluation of self-adjuvanting lipopeptide nano-vaccine platforms for the induction of potent CD8(+) T-cell responses.

Apte SH, Stephenson RJ, Simerska P, Groves PL, Aljohani S, Eskandari S, Toth I, Doolan DL. Apte SH, et al. Among authors: simerska p. Nanomedicine (Lond). 2016 Jan;11(2):137-52. doi: 10.2217/nnm.15.184. Epub 2015 Dec 11. Nanomedicine (Lond). 2016. PMID: 26653407

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

34 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Results by year